O'Quinn Medical Tower - McNair Campus; Dan L Duncan Comprehensive Cancer Center — Houston, Texas

O'Quinn Medical Tower - McNair Campus; Dan L Duncan Comprehensive Cancer Center is a clinical research site located in Houston, Texas, United States 77054.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

O'Quinn Medical Tower - McNair Campus; Dan L Duncan Comprehensive Cancer Center has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Breast Cancer Stage IV, Ductal Carcinoma In Situ, Atypical Lobular Hyperplasia.

Sponsors: Baylor Breast Care Center, Julie Nangia.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for O'Quinn Medical Tower - McNair Campus; Dan L Duncan Comprehensive Cancer Center?

O'Quinn Medical Tower - McNair Campus; Dan L Duncan Comprehensive Cancer Center has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has O'Quinn Medical Tower - McNair Campus; Dan L Duncan Comprehensive Cancer Center conducted?

O'Quinn Medical Tower - McNair Campus; Dan L Duncan Comprehensive Cancer Center has 2 clinical trials on record, with 2 currently active. Their work covers Breast Cancer Stage IV, Ductal Carcinoma In Situ, Atypical Lobular Hyperplasia.

Is O'Quinn Medical Tower - McNair Campus; Dan L Duncan Comprehensive Cancer Center accredited by Crixeo Health?

O'Quinn Medical Tower - McNair Campus; Dan L Duncan Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about O'Quinn Medical Tower - McNair Campus; Dan L Duncan Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.